Anticoagulation in Patients With Acute Renal Failure Treated With Continuous Renal Replacement Therapies

1998 ◽  
Vol 2 (1) ◽  
pp. 41-59 ◽  
Author(s):  
Andrew Davenport
2002 ◽  
Vol 40 (2) ◽  
pp. 275-279 ◽  
Author(s):  
Stanislao Morgera ◽  
Anne K. Kraft ◽  
Gerda Siebert ◽  
Friedrich C. Luft ◽  
Hans-H. Neumayer

1992 ◽  
Vol 3 (3) ◽  
pp. 597-604
Author(s):  
Christy A. Price

Acute renal failure in the critically ill patient is associated with high mortality. Often these patients are hemodynamically unstable, require judicious fluid management, and have a variety of electrolyte abnormalities and acid/ base disturbances. Therapeutic intervention is a necessity, but the patient may not tolerate an aggressive approach. Renal replacement therapies have advanced over the years to modalities that allow for improved management of the patient with acute renal failure. The content to follow will bring new promise to the treatment of acute renal failure employing continuous renal replacement therapy


1997 ◽  
Vol 20 (6) ◽  
pp. 309-315 ◽  
Author(s):  
H-J. Guth ◽  
M. Wiersbitzky ◽  
M. Ziesche ◽  
H-J. Rose ◽  
G. Kraatz

The removal of amino acids during continuous renal replacement therapies induces clinical problems. Previous studies on animals have shown nephroprotective (glycine, alanine) or negative effects (lysine) on renal function in occurrence of acute renal failure. Disturbed metabolism in acute renal failure needs adequate parenteral nutrition. On the other hand, experience with continuous renal replacement therapies of metabolic crises in inborn errors of metabolism indicate a good control of disturbed amino acid metabolism. The aim of our study was to find amino acids, that might play an important role in the pathogenesis, prognosis and detection of acute renal failure and severe illness, so far only estimated by lactic acid. Thirty-three probes (serum and hemofiltrate) were taken from patients, suffering with acute renal failure caused by septic shock, severe pancreatitis and hepatorenal syndrome, one hour after the beginning of extracorporal circulation, the conditions of treatment were standardized. The material was deproteinized and studied by the amino acid analyzer LBK 4251 Apha Plus (Pharmacia, Stockholm, Sweden), while the lactic acid concentration was determined in a standard laboratory. Proline, glycine, alanine, methionine and histidine showed a close relationship to the lactic acid levels, but these amino acids were an essential part of parenteral nutrition. A statistical relationship was also established in (amino acids with amide groups) asparagine, glutamine, citrulline, cystathionine and phosphoethanolamine. The mean values of most of the amino acids were higher than normal, but standard deviations were increased. The presence of these amino acids in hemofiltrate and the good sieving coefficients could mean that the better prognosis of critically ill patients in continuous renal replacement therapies may also be due to continuous control of amino acid levels (especially with amide groups).


2001 ◽  
Vol 21 (4) ◽  
pp. 390-394 ◽  
Author(s):  
Joseph T. Flynn ◽  
David B. Kershaw ◽  
William E. Smoyer ◽  
Patrick D. Brophy ◽  
Kevin D. McBryde ◽  
...  

Background While the use of continuous renal replacement therapies in the management of children with acute renal failure (ARF) has increased, the role of peritoneal dialysis (PD) in the treatment of pediatric ARF has received less attention. Design Retrospective database review of children requiring PD for ARF over a 10-year period. Setting Pediatric intensive care unit at a tertiary-care referral center. Patients Sixty-three children without previously known underlying renal disease who required PD for treatment of ARF. Results Causes of ARF were congestive heart failure (27), hemolytic-uremic syndrome ( 13 ), sepsis ( 10 ), nonrenal organ transplant ( 7 ), malignancy ( 3 ), and other ( 3 ). Mean duration of PD was 11 ± 13 days. Children with ARF were younger (30 ± 48 months vs 88 ± 68 months old, p < 0.0001) and smaller (11.9 ± 15.9 kg vs 28 ± 22 kg, p < 0.0001) than children with known underlying renal disease who began PD during the same time period. Percutaneously placed PD catheters were used in 62% of children with ARF, compared to 4% of children with known renal disease ( p < 0.0001). Hypotension was common in patients with ARF (46%), which correlated with a high frequency of vasopressor use (78%) at the time of initiation of PD. Complications of PD occurred in 25% of patients, the most common being catheter malfunction. Recovery of renal function occurred in 38% of patients; patient survival was 51%. Conclusions Peritoneal dialysis remains an appropriate therapy for pediatric ARF from many causes, even in severely ill children requiring vasopressor support. Such children can be cared for without the use of more expensive and technology-dependent forms of renal replacement therapies.


Sign in / Sign up

Export Citation Format

Share Document